Pharmaceutics

This page contains key pharmaceutical news on drug recalls, FDA clearance, safety communications and research. In cardiology, key pharmaceutic agents include antiplatelet therapies, anticoagulants, hypertension drugs, and drugs for heart failure and arrhythmias.

Dexcom issues new recall for CGM apps due to safety risk—users urged to update immediately
The FDA has categorized this as a Class I recall. If patients update their phone or watch apps as needed, they can continue to use these devices like normal.
Why all heart patients should be vaccinated against the flu, COVID-19, RSV
The American College of Cardiology has shared new recommendations highlighting the protective benefits of a variety of vaccines. The new guidance also examines how to speak with patients who are hesitant to be vaccinated.
First study of its kind to focus on new therapy for hypoplastic left heart syndrome
The new trial represents a potential breakthrough in the treatment of one of the most devastating congenital heart defects.
Real-world data link semaglutide, tirzepatide to improved heart failure outcomes
GLP-1 drugs have been taking the United States by storm in recent years. According to a new study of more than 90,000 patients, some of these medications can also make a big impact on reducing adverse heart failure outcomes.
Beta blockers ‘have no effect’ on heart attack patients
One researcher described the study's findings as "one of the most significant advances in heart attack treatment in decades.”

ASCVD events, death more likely when patients ignore statin recommendations

These findings have important clinical implications for ASCVD prevention.

Edoxaban comparable to VKAs for treating AFib after TAVR

Researchers shared their findings at ESC Congress 2021 and in the New England Journal of Medicine.

Rivaroxaban limits adverse limb and cardiovascular events in surgically treated PAD patients

Rivaroxaban was associated with more bleeding than a placebo, researchers observed, but the overall incidence of such events was still low.

Statin use prior to hospitalization linked to lower COVID-19 mortality

The trend is particularly noticeable in patients with a history of CVD or hypertension.

Chronic liver disease associated with worse PCI outcomes

Researchers tracked data from more than 54,000 adult patients with CLD who underwent PCI from 2004 to 2015.

FDA pushes for statin warnings to be updated

It has long been believed that patients should not take statins while they are pregnant. Now, however, the FDA is emphasizing that there are certain exceptions to that rule.

Prasugrel outperforms ticagrelor among PCI patients

The study's authors tracked data from more than 3,000 patients who underwent PCI for acute coronary syndrome.

Ticagrelor vs. prasugrel for severe heart attack patients undergoing PCI

A new study, published in Circulation, tracked how each drug helped STEMI patients undergoing primary PCI.

Pharmaceutics

Dexcom issues new recall for CGM apps due to safety risk—users urged to update immediately

Why all heart patients should be vaccinated against the flu, COVID-19, RSV

First study of its kind to focus on new therapy for hypoplastic left heart syndrome

Real-world data link semaglutide, tirzepatide to improved heart failure outcomes

Beta blockers ‘have no effect’ on heart attack patients